Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
RA Capital Healthcare Fund LP bought 160,354 Artiva Biotherapeutics, Inc. shares (Form 4)
Traded Jul 16 to Jul 17, 2026 · Filed Jul 20, 2026
From Jul 16 to Jul 17, 2026, RA Capital Healthcare Fund LP (Director, 10% owner) bought 160,354 Artiva Biotherapeutics, Inc. shares at an average US$8.93 for US$1.43M, leaving 16,977,927 shares. Filed Jul 20, 2026 (Form 4).
- Bought
- 160,354 shares
- Price
- US$8.93 average (US$8.93 to US$8.95)
- Value
- US$1.43M
- Holding after
- 16,977,927 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Common Stock | Buy | 152,472 | US$8.93 | 16,970,045 | Indirect |
| Jul 17, 2026 | Common Stock | Buy | 7,882 | US$8.95 | 16,977,927 | Indirect |
Source
Related
- Artiva Biotherapeutics, Inc.
- RA Capital Healthcare Fund LP
- Artiva Biotherapeutics, Inc. shareholders
- Form 4 · RA Capital Healthcare Fund LP · Jul 31, 2026
- Form 4 · Aslan Fred · Oct 7, 2026
- Form 4 · Aslan Fred · Oct 6, 2026
- Form 4 · Banerjee Subhashis · Oct 6, 2026
- Form 4 · Bush Jennifer · Oct 6, 2026
- Form 4 · Horan Christopher · Oct 6, 2026